$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 38.35 | 20,000 | 767,000 | 0 | |
| Jun 15 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 42.27 | 18,289 | 773,076 | 48,980 | 67.3 K to 49 K (-27.19 %) |
| Jun 15 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 38.35 | 20,000 | 767,000 | 67,269 | 47.3 K to 67.3 K (+42.31 %) |
| May 28 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Sell | S | 40.12 | 38,843 | 1,558,381 | 95,000 | 133.8 K to 95 K (-29.02 %) |
| May 28 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Sell | S | 40.01 | 8,482 | 339,365 | 133,843 | 142.3 K to 133.8 K (-5.96 %) |
| Apr 14 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 25,000 | 0 | 47,269 | 72.3 K to 47.3 K (-34.59 %) |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 33.93 | 442 | 14,997 | 95,894 | 95.5 K to 95.9 K (+0.46 %) |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 33.93 | 464 | 15,744 | 61,941 | 61.5 K to 61.9 K (+0.75 %) |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 33.93 | 464 | 15,744 | 346,795 | 346.3 K to 346.8 K (+0.13 %) |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 33.93 | 208 | 7,057 | 8,273 | 8.1 K to 8.3 K (+2.58 %) |
| Mar 04 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 26.58 | 20,000 | 531,600 | 0 | |
| Mar 04 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 34.93 | 15,250 | 532,683 | 72,269 | 87.5 K to 72.3 K (-17.42 %) |
| Mar 04 2021 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 26.58 | 20,000 | 531,600 | 87,519 | 67.5 K to 87.5 K (+29.62 %) |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 23,719 | 0 | 23,719 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | A | 36.89 | 18,714 | 690,359 | 18,714 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 22,364 | 0 | 22,364 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 36.89 | 17,644 | 650,887 | 17,644 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 23,719 | 0 | 23,719 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 36.89 | 18,714 | 690,359 | 18,714 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 67,769 | 0 | 67,769 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 36.89 | 53,471 | 1,972,545 | 53,471 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,354 | 0 | 16,708 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 38.87 | 200 | 7,774 | 23,104 | 23.3 K to 23.1 K (-0.86 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 39.28 | 2,534 | 99,536 | 23,304 | 25.8 K to 23.3 K (-9.81 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Buy | M | 0.00 | 8,354 | 0 | 25,838 | 17.5 K to 25.8 K (+47.78 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 11,139 | 0 | 22,278 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 38.90 | 600 | 23,340 | 45,339 | 45.9 K to 45.3 K (-1.31 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 39.26 | 4,584 | 179,968 | 45,939 | 50.5 K to 45.9 K (-9.07 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 11,139 | 0 | 50,523 | 39.4 K to 50.5 K (+28.28 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 10,442 | 0 | 20,886 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 38.91 | 1,200 | 46,692 | 0 | 1.2 K to 0 (-100.00 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 39.27 | 9,242 | 362,933 | 1,200 | 10.4 K to 1.2 K (-88.51 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 10,442 | 0 | 10,442 | 0 to 10.4 K |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 11,139 | 0 | 22,278 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 38.91 | 1,100 | 42,801 | 0 | 1.1 K to 0 (-100.00 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 39.28 | 10,039 | 394,332 | 1,100 | 11.1 K to 1.1 K (-90.12 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 11,139 | 0 | 11,139 | 0 to 11.1 K |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 27,847 | 0 | 55,695 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 38.91 | 3,100 | 120,621 | 1,133,392 | 1.1 M to 1.1 M (-0.27 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 39.27 | 24,747 | 971,815 | 1,136,492 | 1.2 M to 1.1 M (-2.13 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 27,847 | 0 | 1,161,239 | 1.1 M to 1.2 M (+2.46 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,092 | 0 | 13,093 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 31.60 | 100 | 3,160 | 17,484 | 17.6 K to 17.5 K (-0.57 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 32.13 | 4,267 | 137,099 | 17,584 | 21.9 K to 17.6 K (-19.53 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Buy | M | 0.00 | 13,092 | 0 | 21,851 | 8.8 K to 21.9 K (+149.47 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 20,948 | 0 | 20,948 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 32.02 | 9,684 | 310,082 | 39,384 | 49.1 K to 39.4 K (-19.74 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 20,948 | 0 | 49,068 | 28.1 K to 49.1 K (+74.50 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 19,638 | 0 | 19,639 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.64 | 2,376 | 75,177 | 0 | 2.4 K to 0 (-100.00 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 32.07 | 17,262 | 553,592 | 2,376 | 19.6 K to 2.4 K (-87.90 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 19,638 | 0 | 19,638 | 0 to 19.6 K |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 350 | 0 | 0 | 350 to 0 (-100.00 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 19,638 | 0 | 19,639 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 31.65 | 1,936 | 61,274 | 0 | 1.9 K to 0 (-100.00 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 32.07 | 17,702 | 567,703 | 1,936 | 19.6 K to 1.9 K (-90.14 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 19,638 | 0 | 19,638 | 0 to 19.6 K |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 41,896 | 0 | 41,896 | |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 31.64 | 4,585 | 145,069 | 1,133,392 | 1.1 M to 1.1 M (-0.40 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 32.06 | 37,311 | 1,196,191 | 1,137,977 | 1.2 M to 1.1 M (-3.17 %) |
| Jan 12 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 41,896 | 0 | 1,175,288 | 1.1 M to 1.2 M (+3.70 %) |
| Dec 21 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 34,000 | 93,160 | 0 | |
| Dec 21 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 34,000 | 93,160 | 1,147,392 | 1.1 M to 1.1 M (+3.05 %) |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | G | 38.35 | 20,000 | 767,000 | 20,000 | |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | G | 38.35 | 20,000 | 767,000 | 0 | |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | G | 26.58 | 20,000 | 531,600 | 20,000 | |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | G | 26.58 | 20,000 | 531,600 | 0 | |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 28,379 | 0 | 67,519 | 39.1 K to 67.5 K (+72.51 %) |
| Dec 18 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 28,379 | 0 | 0 | 28.4 K to 0 (-100.00 %) |
| Nov 19 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 13.86 | 75,000 | 1,039,500 | 25,000 | |
| Nov 19 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 27.95 | 3,761 | 105,120 | 0 | 3.8 K to 0 (-100.00 %) |
| Nov 19 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 27.60 | 75,664 | 2,088,326 | 3,761 | 79.4 K to 3.8 K (-95.26 %) |
| Nov 19 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 13.86 | 75,000 | 1,039,500 | 79,425 | 4.4 K to 79.4 K (+1,694.92 %) |
| Nov 13 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 3.26 | 10,000 | 32,600 | 0 | |
| Nov 13 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 2.84 | 10,000 | 28,400 | 0 | |
| Nov 13 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 25.41 | 28,034 | 712,344 | 0 | 28 K to 0 (-100.00 %) |
| Nov 13 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 3.26 | 10,000 | 32,600 | 28,034 | 18 K to 28 K (+55.45 %) |
| Nov 13 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 2.84 | 10,000 | 28,400 | 18,034 | 8 K to 18 K (+124.47 %) |
| Nov 12 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 26.91 | 19,131 | 514,815 | 1,113,392 | 1.1 M to 1.1 M (-1.69 %) |
| Nov 12 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 25.99 | 30,869 | 802,285 | 1,132,523 | 1.2 M to 1.1 M (-2.65 %) |
| Nov 06 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 25.00 | 50,000 | 1,250,000 | 1,163,392 | 1.2 M to 1.2 M (-4.12 %) |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 13,448 | |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 26.80 | 6,792 | 182,026 | 28,120 | 34.9 K to 28.1 K (-19.45 %) |
| Oct 16 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 34,912 | 21.5 K to 34.9 K (+62.65 %) |
| Oct 02 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 25.66 | 584 | 14,985 | 94,981 | 94.4 K to 95 K (+0.62 %) |
| Sep 14 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 29.60 | 49,500 | 1,465,200 | 4,743,770 | 4.7 M to 4.7 M (+1.05 %) |
| Sep 11 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 12.73 | 26,983 | 343,494 | 53,968 | |
| Sep 11 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.14 | 41,983 | 1,307,351 | 8,034 | 50 K to 8 K (-83.94 %) |
| Sep 11 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 12.73 | 26,983 | 343,494 | 50,017 | 23 K to 50 K (+117.14 %) |
| Sep 11 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 28.08 | 21,000 | 589,680 | 4,694,270 | 4.7 M to 4.7 M (+0.45 %) |
| Jul 10 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | G | 16.86 | 20,000 | 337,200 | 0 | |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 25.67 | 275 | 7,059 | 7,567 | 7.3 K to 7.6 K (+3.77 %) |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 25.67 | 584 | 14,991 | 94,397 | 93.8 K to 94.4 K (+0.62 %) |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 25.67 | 613 | 15,736 | 60,369 | 59.8 K to 60.4 K (+1.03 %) |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 25.67 | 613 | 15,736 | 345,223 | 344.6 K to 345.2 K (+0.18 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 0.00 | 14,005 | 0 | 28,379 | 14.4 K to 28.4 K (+97.43 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | M | 0.00 | 14,005 | 0 | 59,756 | 45.8 K to 59.8 K (+30.61 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 0.00 | 14,005 | 0 | 28,379 | 14.4 K to 28.4 K (+97.43 %) |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | M | 0.00 | 14,005 | 0 | 0 | |
| Jun 26 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | M | 0.00 | 14,005 | 0 | 59,756 | 45.8 K to 59.8 K (+30.61 %) |
| May 28 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 22.02 | 20,000 | 440,400 | 20,000 | |
| May 28 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 22.02 | 20,000 | 440,400 | 20,000 | |
| May 28 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 22.02 | 20,000 | 440,400 | 20,000 | |
| May 28 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 13,767 | 0 | 13,767 | |
| May 28 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 13,767 | 0 | 13,767 | |
| May 15 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 20.04 | 9,602 | 192,424 | 39,140 | 48.7 K to 39.1 K (-19.70 %) |
| May 13 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 19.95 | 50,000 | 997,500 | 48,742 | 98.7 K to 48.7 K (-50.64 %) |
| May 13 2020 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 20.63 | 7,297 | 150,537 | 14,374 | 21.7 K to 14.4 K (-33.67 %) |
| May 13 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| May 13 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| May 13 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Sell | S | 20.50 | 3,500 | 71,750 | 93,813 | 97.3 K to 93.8 K (-3.60 %) |
| May 13 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | M | 2.74 | 25,000 | 68,500 | 97,313 | 72.3 K to 97.3 K (+34.57 %) |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 15.37 | 1,024 | 15,739 | 344,610 | 343.6 K to 344.6 K (+0.30 %) |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 15.37 | 975 | 14,986 | 72,313 | 71.3 K to 72.3 K (+1.37 %) |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 15.37 | 460 | 7,070 | 7,292 | 6.8 K to 7.3 K (+6.73 %) |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 15.37 | 1,024 | 15,739 | 45,751 | 44.7 K to 45.8 K (+2.29 %) |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 83,542 | 0 | 83,542 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 23.94 | 66,886 | 1,601,251 | 66,886 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 33,417 | 0 | 33,417 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 23.94 | 26,754 | 640,491 | 26,754 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 31,328 | 0 | 31,328 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 23.94 | 25,082 | 600,463 | 25,082 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 33,417 | 0 | 33,417 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 23.94 | 26,754 | 640,491 | 26,754 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 33,417 | 0 | 33,417 | |
| Feb 20 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 23.94 | 26,754 | 640,491 | 26,754 | |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | J | 23.61 | 3,809 | 89,930 | 4,425 | 8.2 K to 4.4 K (-46.26 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 8,043 | 0 | 8,234 | 191 to 8.2 K (+4,210.99 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | J | 23.61 | 3,809 | 89,930 | 23,034 | 26.8 K to 23 K (-14.19 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 8,043 | 0 | 26,843 | 18.8 K to 26.8 K (+42.78 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | J | 23.61 | 9,323 | 220,116 | 1,213,392 | 1.2 M to 1.2 M (-0.76 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 18,008 | 0 | 1,222,715 | 1.2 M to 1.2 M (+1.49 %) |
| Jan 16 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 34.31 | 400 | 13,724 | 71,338 | 70.9 K to 71.3 K (+0.56 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 22,911 | 0 | 45,824 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Sell | S | 26.16 | 11,573 | 302,750 | 11,338 | 22.9 K to 11.3 K (-50.51 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Buy | M | 0.00 | 22,911 | 0 | 22,911 | 0 to 22.9 K |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 20,947 | 0 | 41,896 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | J | 26.34 | 6,157 | 162,175 | 21,464 | 27.6 K to 21.5 K (-22.29 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 20,947 | 0 | 27,621 | 6.7 K to 27.6 K (+313.86 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 26.16 | 41,895 | 1,095,973 | 1,204,707 | 1.2 M to 1.2 M (-3.36 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 26.16 | 19,638 | 513,730 | 191 | 19.8 K to 191 (-99.04 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 26.16 | 19,638 | 513,730 | 18,800 | 38.4 K to 18.8 K (-51.09 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 16,000 | 43,840 | 34,000 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 44,000 | 120,560 | 0 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 41,895 | 0 | 83,792 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 16,000 | 43,840 | 1,246,602 | 1.2 M to 1.2 M (+1.30 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 44,000 | 120,560 | 1,230,602 | 1.2 M to 1.2 M (+3.71 %) |